Director Shareholding

GlaxoSmithKline PLC
26 July 2001

                             Directors' Interests



I give below details of changes in directors' interests in the Ordinary Shares
of GlaxoSmithKline plc.



9     The Administrators of the SmithKline Beecham US Retirement Savings Plan
July  ('the Plan') notified GlaxoSmithKline plc on the 24 July 2001, that as a
2001  result of movement in the fund on the 9 July 2001, the number of Ordinary
      Share ADRs held by the fund had increased from 16,198,055 to 18,588,496
      at an average price of $57.2900.

13    The Administrators of the SmithKline Beecham US Retirement Savings Plan
July  ('the Plan') notified GlaxoSmithKline plc on the 24 July 2001, that as a
2001  result of movement in the fund on the 13 July 2001, the number of
      Ordinary Share ADRs held by the fund had decreased from 18,588,496 to
      18,576,813 at an average price of $56.4900.

20    The Administrators of the SmithKline Beecham US Retirement Savings Plan
July  ('the Plan') notified GlaxoSmithKline plc on the 24 July 2001, that as a
2001  result of movement in the fund on the 20 July 2001, the number of
      Ordinary Share ADRs held by the fund had decreased from 18,576,813 to
      18,546,303 at an average price of $57.6000.


The Plan is a discretionary fund of which all employees or former employees of
SmithKline Beecham plc and its subsidiaries are potential beneficiaries. One
of the Company's directors, Dr J P Garnier is therefore, interested in the
shares held in the fund from time to time in the same way as other employees
or former employees of SmithKline Beecham plc and its subsidiaries.






S M Bicknell

Company Secretary


26 July 2001